New Clinical Trial Underway for Treatment of Advanced Melanoma
News
A new clinical trial is underway assessing the addition of the first-in-class AXL kinase inhibitor, BGB324, to standard of care treatment for patients with advanced unresectable or metastatic melanoma. The Phase 1/2 clinical trial ... Read more